Hyderabad: Dr Reddy''s Laboratories (DRL) is setting up two special economic zones (SEZs) - one each at Hyderabad and Visakhapatnam in Andhra Pradesh. One SEZ will be exclusively for active pharmaceutical ingredients, the second will be for other pharmaceutical products.

The company has a capital expenditure programme of $100 million (over Rs400 crore) said G V Prasad, vice-chairman and chief executive officer, DRL. He added that the company would continue its geographical expansion and also enhance its growth into oncology and bio-generic products.

Dr Reddy''s would launch 10 new products in the current financial year.